Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mutsumi Miyamoto

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Veterinary Internal Medicine|June 8, 2007
Effects of 4 classes of cardiovascular drugs on ventricular function in dogs with mitral regurgitationTomohiro Nakayama, Yoshinori Nishijima, Mutsumi Miyamoto, et al.
Inhalation Toxicology|October 7, 2017
Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosisMatthew P Walker, Matt Cowlen, Dale Christensen, et al.
Journal of Pharmacological and Toxicological Methods|April 24, 2012
Cardiorespiratory safety evaluation in non-human primatesJennifer L Ingram-Ross, Aidan K Curran, Mutsumi Miyamoto, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Veterinary Internal Medicine|June 8, 2007
Effects of 4 classes of cardiovascular drugs on ventricular function in dogs with mitral regurgitationTomohiro Nakayama, Yoshinori Nishijima, Mutsumi Miyamoto, et al.
Inhalation Toxicology|October 7, 2017
Nonclinical safety assessment of SPX-101, a novel peptide promoter of epithelial sodium channel internalization for the treatment of cystic fibrosisMatthew P Walker, Matt Cowlen, Dale Christensen, et al.
Journal of Pharmacological and Toxicological Methods|April 24, 2012
Cardiorespiratory safety evaluation in non-human primatesJennifer L Ingram-Ross, Aidan K Curran, Mutsumi Miyamoto, et al.
Pageof 1